Healthcare

The Equity in STI Testing Act requires Medicare Advantage, Medicaid, CHIP, TRICARE, and the Department of Veterans Affairs to cover screening tests for HIV, gonorrhea, syphilis, trichomoniasis, and chlamydia without charging beneficiaries any out-of-pocket costs. The bill directly affects patients enrolled in these federal health programs by eliminating copayments and deductibles specifically for these preventive screenings. It also mandates that the Indian Health Service provide these tests to eligible Native Americans at no cost, regardless of whether the services are typically authorized under their purchased or referred care systems. These changes take effect on different timelines depending on the specific program, with some provisions applying immediately upon enactment and others starting in the following calendar year.

The Launching with Healthcare Act extends the period during which young adults must be covered under their parents' health insurance plans from age 26 to age 31. This change directly affects individuals up to age 31 and the employers or insurers providing these family coverage plans. The bill amends the Public Health Service Act to implement this new age limit, with the provision taking effect for plan years that begin after December 31, 2026.

This bill amends Medicare to cover dental and oral health services for the first time, affecting all current and future Medicare beneficiaries. It defines covered services to include routine cleanings, fillings, extractions, root canals, crowns, dentures, and emergency care. For most individuals, federal payment for these services will gradually increase from 0% to 80% over an eight-year period, while low-income individuals eligible for prescription drug subsidies will receive 80% coverage immediately. The legislation also establishes frequency limits, such as two cleanings and exams per year and a five-year limit on full dentures, and requires the U.S. Preventive Services Task Force to include at least one oral health professional.

The End Tuberculosis Now Act of 2026 amends the Foreign Assistance Act to designate ending the global tuberculosis emergency as a major objective of U.S. foreign policy and authorizes the President to provide funding for prevention, diagnosis, and treatment programs worldwide. The bill sets specific targets to be achieved by 2030, including an 80 percent reduction in new infections and a 90 percent reduction in deaths compared to 2015 levels, while also requiring that 30 million individuals receive preventive treatment. Key provisions mandate the use of innovative diagnostic tools, support for drug-resistant TB care, and coordination with private sector partners to develop vaccines and lower treatment costs. The legislation requires annual reports to Congress detailing program progress and expenditures, and it includes a sunset clause that terminates these specific authorities on January 1, 2033.

This House resolution expresses support for designating September 2026 as National Prostate Cancer Awareness Month to highlight the disease's impact on men in the United States. It calls on the public, interest groups, and affected individuals to promote awareness of screening methods and participate in ceremonies observing the month. The text also urges steps to encourage research into prevention, early detection, and cures, while improving access to quality health care services for prostate cancer treatment.

The Americans vs. Poisonous Pesticides Act amends federal pesticide laws to allow state courts to hear lawsuits alleging that pesticide labels fail to warn about health or environmental risks. It clarifies that a pesticide's federal registration and label approval do not automatically block these state claims, though they serve as initial evidence of compliance. The bill also permits companies to update their product labels to address new safety information without waiting for prior government approval, subject to potential review by the agency. These changes apply to both new lawsuits and cases already in progress, ensuring that federal rules do not limit existing state legal remedies for damages or injunctive relief.

The Part D Premium Protection Act of 2026 would establish a temporary premium credit for Medicare Part D prescription drug plan enrollees in 2027. This credit is designed to match the average premium reduction observed during the Part D Premium Stabilization Demonstration program between January 1, 2025, and the end of 2026. Under the bill's provisions, insurance sponsors would charge enrollees their standard premiums minus this specific credit amount, with the floor set at zero dollars. The Secretary of Health and Human Services would then reimburse the sponsors for the difference between the charged premium and the full applicable rate.

The PROTECT Act directs the Centers for Disease Control and Prevention to launch a five-year initiative aimed at reducing youth and young adult use of e-cigarettes and other emerging tobacco products. The bill authorizes $500 million in funding over five years to support research on usage patterns, health impacts, and cessation behaviors, as well as the development of new prevention strategies and public education campaigns. It also requires the creation of guidance for healthcare providers and schools on how to intervene with young users and improve access to quitting services. Additionally, the legislation mandates continued funding for state and local health departments to implement these prevention and cessation efforts.

The SMASH 2.0 Act reauthorizes and updates the federal Mosquito Abatement for Safety and Health program, which provides funding to state and local health departments to control mosquito populations. Key provisions allow the use of innovative technologies for prevention, allocate funds for technical training and education for public health workers, and increase the program's funding level to $100 million annually for fiscal years 2027 through 2031. Additionally, the bill requires the creation of a strategic plan to stockpile emergency supplies for controlling vector-borne diseases and establishes a mechanism for coordination with the Strategic National Stockpile. These changes aim to enhance the capacity of health agencies to manage mosquito-related health risks through better planning, training, and resource availability.

The Green New Deal for Health Act establishes a comprehensive federal framework to address the health impacts of climate change by creating new offices, expanding funding, and mandating specific actions across the health care sector. It directly affects hospitals, medical facilities, health care workers, and communities, with a specific focus on protecting environmental justice and low-income populations from climate-related health risks. Key provisions include the creation of an Office of Climate Change and Health Equity to develop a national strategic plan, requirements for hospitals to provide extended notice before closing or reducing essential services, and significant grants to upgrade medical facilities for climate resilience. The bill also mandates that the health care sector reduce its own carbon emissions through new disclosure rules for medical supplies and grants for green manufacturing, while simultaneously funding education to train health professionals on climate-related health threats. Additionally, the legislation authorizes Medicare coverage for home resiliency services, such as heat pumps and solar batteries, for individuals at risk during climate disasters, and allocates billions of dollars to expand the community health workforce and support mental health resilience programs.